We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of 0.87% as an H1B industry with 322 employees hired as of 2024


Top In-Vitro Diagnostic Substance Manufacturing Employers

Company Employees Average Wage
Nanobio Systems Inc. 1 $61,922
Poc Medical Systems, Inc. 1 $97,490
Premier Medical Usa Corporation 1 $54,059
Rhodx Inc. 1 $74,526
Streck, Inc. 1 $63,274
Telcare, Inc. 1 $44,429
Wondfo Usa Co., Ltd. 1 $75,254


Top In-Vitro Diagnostic Substance Manufacturing Jobs

Job Title Number of Jobs Average Wage
Sales Engineers 2 $120,682
Materials Scientists 2 $111,884
Computer Systems Analysts 1 $118,061
Financial Analysts 1 $56,077
Computer Occupations, All Other 1 $64,938
Budget Analysts 1 $73,424
Human Resources Specialists 1 $44,304
Logistics Analysts 1 $84,032
Validation Engineers 1 $100,402
Logisticians 1 $78,707

Employees Over Time vs Average Salary Over Time

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where 6 employees were hired. They peaked in 2023 with 43 employees, and the recent trend shows the average number of employees on an incline.
The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where the average salary was $49,299. The industry peaked in 2023 with an average salary of $97,967, and the recent trend shows the average salary on an incline.